CD274 and neoplasm: The fact that PD-L1 expression is intrinsically dynamic and generalized to a wide range of immune cells means that therapeutic decisions concerning patient access to anti-PD-1/PD-L1 treatments based on tumor PD-L1 expression exclusively are quite limited since other immune contributions are being ignored that could have an important contribution to predicting clinical responses to these treatments.